Details for Patent: 8,450,299
Summary for Patent: 8,450,299
| Title: | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
| Abstract: | The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits. |
| Inventor(s): | Charles E. Diliberti, Kathleen Z. Reape, Lance J. Bronnenkant |
| Assignee: | Teva Womens Health Inc |
| Application Number: | US13/492,138 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,450,299 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,450,299
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,450,299
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 051931 | ⤷ Start Trial | |||
| Australia | 2005294269 | ⤷ Start Trial | |||
| Brazil | PI0516247 | ⤷ Start Trial | |||
| Brazil | PI0716291 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
